Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Cover

v3.22.4
Cover
 12 Months Ended
Dec. 31, 2022
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Period End Date Dec. 31, 2022
Current Fiscal Year End Date --12-31
Document Transition Report false
Document Shell Company Report false
Entity File Number 001-38512
Entity Registrant Name ONCOLYTICS BIOTECH INC.
Entity Incorporation, State or Country Code A0
Entity Address, Address Line One 804, 322 11th Avenue SW
Entity Address, City or Town Calgary
Entity Address, State or Province AB
Entity Address, Country CA
Entity Address, Postal Zip Code T2R 0C5
Title of 12(b) Security no
Trading Symbol ONCY
Security Exchange Name NASDAQ
Entity Common Stock, Shares Outstanding 61,327,914
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
ICFR Auditor Attestation Flag false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Central Index Key 0001129928
Document Fiscal Year Focus 2022
Document Fiscal Period Focus FY
Amendment Flag false
Business Contact  
Document Information [Line Items]  
Entity Address, Address Line One 804, 322 11th Avenue SW
Entity Address, City or Town Calgary
Entity Address, State or Province AB
Entity Address, Country CA
Entity Address, Postal Zip Code T2R 0C5
Contact Personnel Name Kirk Look
City Area Code 403
Local Phone Number 670-7377
Contact Personnel Email Address info@oncolytics.ca